{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:44:25Z","timestamp":1792683865649,"version":"4.5.0"},"reference-count":87,"publisher":"Oxford University Press (OUP)","issue":"1213","license":[{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Patients with chronic coronary syndromes deserve high attention and tailored management for the effective reduction of the residual cardiovascular risk. Long-term secondary prevention strategies are the key to reaching this goal and mitigating the overall cardiovascular burden. Four pillars should be the cornerstones of the management of patients with chronic coronary syndromes: lifestyle interventions, cardiac rehabilitation, risk factor control and achievement of treatment targets, and guideline-directed medical therapy. These interventions should be personalized to achieve prevention and treatment goals in order to improve prognosis and health-related quality of life. Herein, we present a state-of-the-art review on the comprehensive cardiovascular risk assessment and secondary prevention among patients with chronic coronary syndromes. In addition, we provide practical guidance for the management of this patient population in complex clinical scenarios and specific groups, including those with heart failure, older adults, sex-specific considerations, high bleeding risk, atrial fibrillation, and chronic kidney disease.<\/jats:p>","DOI":"10.1093\/postmj\/qgag022","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T12:03:42Z","timestamp":1774353822000},"page":"1008-1017","source":"Crossref","is-referenced-by-count":1,"title":["Secondary prevention and cardiac rehabilitation in patients with chronic coronary syndromes: long-term management and treatment"],"prefix":"10.1093","volume":"102","author":[{"given":"Aristi","family":"Boulmpou","sequence":"first","affiliation":[{"name":"Third Department of Cardiology, Aristotle University of Thessaloniki, Ippokratio General Hospital , 54642 Thessaloniki ,","place":["Greece"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Alexandra","family":"Ciuca-Pana","sequence":"additional","affiliation":[{"name":"Cardiology Department\u2014Faculty of Medicine, University of Medicine and Pharmacy Carol Davila , 030167 Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigdem","family":"Ileri","sequence":"additional","affiliation":[{"name":"Department of Cardiology, LIV Hospital Vadi Istanbul , 34396 Istanbul ,","place":["Turkey"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ullah","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Hospitals Cleveland Medical Center , 44106 OH ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Cacciatore","sequence":"additional","affiliation":[{"name":"Department of Geriatrics, Orthopedics and Rheumatology, Universit\u00e0 Cattolica del Sacro Cuore , 00168 Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Spadafora","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome , 04100 Latina ,","place":["Italy"]},{"name":"Cardiology Department, Santa Maria Goretti Hospital , 04100 Latina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bernardi","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome , 04100 Latina ,","place":["Italy"]},{"name":"Cardiology Department, Santa Maria Goretti Hospital , 04100 Latina ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Busnatu","sequence":"additional","affiliation":[{"name":"Cardiology Department\u2014Faculty of Medicine, University of Medicine and Pharmacy Carol Davila , 030167 Bucharest ,","place":["Romania"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Biondi Zoccai","sequence":"additional","affiliation":[{"name":"Department of Medical-Surgical Sciences and Biotechnologies, Sapienza University of Rome , 04100 Latina ,","place":["Italy"]},{"name":"Maria Cecilia Hospital, GVM Care & Research , 48033 Cotignola ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1418-7908","authenticated-orcid":false,"given":"Francesco","family":"Perone","sequence":"additional","affiliation":[{"name":"Cardiac Rehabilitation Unit, Rehabilitation Clinic \u201cVilla delle Magnolie,\u201d \u00a0 81020 Castel Morrone, Caserta ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,3,24]]},"reference":[{"key":"2026102211174666300_ref1","doi-asserted-by":"publisher","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"2026102211174666300_ref2","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1111\/joim.12296","article-title":"Thrombosis formation on atherosclerotic lesions and plaque rupture","volume":"276","author":"Badimon","year":"2014","journal-title":"J Intern Med"},{"key":"2026102211174666300_ref3","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1148\/rg.2021200125","article-title":"Ischemic heart disease: noninvasive imaging techniques and findings","volume":"41","author":"Sirajuddin","year":"2021","journal-title":"Radiographics"},{"key":"2026102211174666300_ref4","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.gheart.2015.04.003","article-title":"Reducing premature cardiovascular morbidity and mortality in people with atherosclerotic vascular disease: the world heart federation roadmap for secondary prevention of cardiovascular disease [published correction appears in Glob Heart. 2015 Sep;10(3):225. Vedanthan, Raj [corrected to Vedanthan, Rajesh]]","volume":"10","author":"Perel","year":"2015","journal-title":"Glob Heart"},{"key":"2026102211174666300_ref5","doi-asserted-by":"publisher","first-page":"5767864","DOI":"10.1155\/2018\/5767864","article-title":"Secondary prevention of cardiovascular diseases and application of technology for early Diagnosis","volume":"8","author":"Karunathilake","year":"2018","journal-title":"Biomed Res Int"},{"key":"2026102211174666300_ref6","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/jcm14051607","article-title":"Exercise training and cardiac rehabilitation in patients after percutaneous coronary intervention: comprehensive assessment and prescription","volume":"14","author":"Adam","year":"2025","journal-title":"J Clin Med"},{"key":"2026102211174666300_ref7","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1161\/CIR.0000000000001168","article-title":"2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients With Chronic Coronary Disease: a report of the American Heart Association\/American College of Cardiology Joint Committee on Clinical Practice Guidelines","volume":"148","author":"Virani","year":"2023","journal-title":"Circulation"},{"key":"2026102211174666300_ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s41043-023-00478-z","article-title":"Bibliometric analysis of residual cardiovascular risk: trends and frontiers","volume":"42","author":"Wang","year":"2023","journal-title":"J Health Popul Nutr"},{"key":"2026102211174666300_ref9","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3390\/jcdd12050171","article-title":"Non-traditional cardiovascular risk factors: tailored assessment and clinical implications","volume":"12","author":"Perone","year":"2025","journal-title":"J Cardiovasc Dev Dis"},{"key":"2026102211174666300_ref10","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/ehjcvp\/pvad074","article-title":"Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular disease","volume":"10","author":"Zheng","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026102211174666300_ref11","doi-asserted-by":"publisher","first-page":"508","DOI":"10.2337\/dbi19-0007","article-title":"Remnants of the triglyceride-rich lipoproteins, diabetes, and cardiovascular disease","volume":"69","author":"Chait","year":"2020","journal-title":"Diabetes"},{"key":"2026102211174666300_ref12","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1161\/ATVBAHA.114.303284","article-title":"Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the atherosclerosis risk in communities (ARIC) study","volume":"34","author":"Hoogeveen","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2026102211174666300_ref13","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0140-6736(10)60713-1","article-title":"HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial","volume":"376","author":"Ridker","year":"2010","journal-title":"Lancet"},{"key":"2026102211174666300_ref14","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.pec.2014.01.012","article-title":"A systematic review of patient education in cardiac patients: do they increase knowledge and promote health behavior change?","volume":"95","author":"Ghisi","year":"2014","journal-title":"Patient Educ Couns"},{"key":"2026102211174666300_ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008895.pub3","article-title":"Patient education in the management of coronary heart disease","volume":"6","author":"Anderson","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102211174666300_ref16","doi-asserted-by":"publisher","first-page":":CD003041","DOI":"10.1002\/14651858.CD003041.pub2","article-title":"Smoking cessation for the secondary prevention of coronary heart disease","author":"Critchley","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102211174666300_ref17","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1253\/circj.CJ-19-0323","article-title":"Effects of tobacco smoking on cardiovascular disease","volume":"83","author":"Kondo","year":"2019","journal-title":"Circ J"},{"key":"2026102211174666300_ref18","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1146\/annurev-med-111314-033712","article-title":"The past, present, and future of nicotine addiction therapy","volume":"67","author":"Prochaska","year":"2016","journal-title":"Annu Rev Med"},{"key":"2026102211174666300_ref19","doi-asserted-by":"publisher","first-page":"CD009825","DOI":"10.1002\/14651858.CD009825.pub3","article-title":"Mediterranean-style diet for the primary and secondary prevention of cardiovascular disease","volume":"2019","author":"Rees","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102211174666300_ref20","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"2026102211174666300_ref21","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.3390\/nu15153356","article-title":"Mediterranean diet for primary and secondary prevention of cardiovascular disease and mortality: an updated systematic review","volume":"15","author":"Laffond","year":"2023","journal-title":"Nutrients"},{"key":"2026102211174666300_ref22","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/joim.13333","article-title":"The Mediterranean diet and health: a comprehensive overview","volume":"290","author":"Guasch-Ferr\u00e9","year":"2021","journal-title":"J Intern Med"},{"key":"2026102211174666300_ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20043337","article-title":"Plant based diet and its effect on cardiovascular disease","volume":"20","author":"Salehin","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026102211174666300_ref24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1177\/2047487319893035","article-title":"Update on cardiovascular prevention in clinical practice: a position paper of the European Association of Preventive Cardiology of the European Society of Cardiology","volume":"27","author":"Piepoli","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"2026102211174666300_ref25","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1111\/add.12828","article-title":"Has the leaning tower of presumed health benefits from 'moderate' alcohol use finally collapsed?","volume":"110","author":"Chikritzhs","year":"2015","journal-title":"Addiction"},{"key":"2026102211174666300_ref26","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of body mass index with lifetime risk of cardiovascular disease and compression of morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2026102211174666300_ref27","doi-asserted-by":"publisher","first-page":"e984","DOI":"10.1161\/CIR.0000000000000973","article-title":"Obesity and cardiovascular disease: a scientific statement from the American Heart Association","volume":"143","author":"Powell-Wiley","year":"2021","journal-title":"Circulation"},{"key":"2026102211174666300_ref28","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss","volume":"53","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026102211174666300_ref29","doi-asserted-by":"publisher","first-page":"364","DOI":"10.26502\/fccm.92920271","article-title":"Exercise in patients with chronic angina pectoris: friend or foe?","volume":"06","author":"Dechend","year":"2022","journal-title":"Cardiol Cardiovasc Med"},{"key":"2026102211174666300_ref30","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.jacc.2022.07.004","article-title":"Exercise for primary and secondary prevention of cardiovascular disease: JACC focus seminar 1\/4","volume":"80","author":"Tucker","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026102211174666300_ref31","doi-asserted-by":"publisher","first-page":"200331","DOI":"10.1016\/j.ijcrp.2024.200331","article-title":"Obesity and cardiovascular disease: risk assessment, physical activity, and management of complications","volume":"5","author":"Perone","year":"2024","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"2026102211174666300_ref32","doi-asserted-by":"publisher","first-page":"200338","DOI":"10.1016\/j.ijcrp.2024.200338","article-title":"Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategies","volume":"28","author":"Rizza","year":"2024","journal-title":"Int J Cardiol Cardiovasc Risk Prev"},{"key":"2026102211174666300_ref33","first-page":"CD008012","article-title":"Psychological and pharmacological interventions for depression in patients with coronary artery disease","volume":"12","author":"Tully","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"2026102211174666300_ref34","doi-asserted-by":"publisher","first-page":"7540","DOI":"10.3390\/jcm12247540","article-title":"Myocardial work assessment in patients after coronary artery bypass grafting during cardiac rehabilitation","volume":"12","author":"Perone","year":"2023","journal-title":"J Clin Med"},{"key":"2026102211174666300_ref35","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40798-017-0086-z","article-title":"The contribution of individual exercise training components to clinical outcomes in randomised controlled trials of cardiac rehabilitation: a systematic review and meta-regression","volume":"3","author":"Abell","year":"2017","journal-title":"Sports Med Open"},{"key":"2026102211174666300_ref36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11936-018-0667-2","article-title":"Cardiac rehabilitation and exercise prescription in symptomatic patients with non-obstructive coronary artery disease\u2014a systematic review","volume":"20","author":"Kissel","year":"2018","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"2026102211174666300_ref37","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1007\/s11606-018-4636-y","article-title":"Efficacy of different types of exercise-based cardiac rehabilitation on coronary heart disease: a network meta-analysis","volume":"33","author":"Xia","year":"2018","journal-title":"J Gen Intern Med"},{"key":"2026102211174666300_ref38","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cjca.2016.08.017","article-title":"Effect of mobile health interventions on the secondary prevention of cardiovascular disease: systematic review and meta-analysis","volume":"33","author":"Gandhi","year":"2017","journal-title":"Can J Cardiol"},{"key":"2026102211174666300_ref39","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1093\/eurjpc\/zwab146","article-title":"Impact of activity trackers on secondary prevention in patients with coronary artery disease: a systematic review and meta-analysis","volume":"29","author":"Kaihara","year":"2022","journal-title":"Eur J Prev Cardiol"},{"key":"2026102211174666300_ref40","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.3390\/ijerph18042023","article-title":"Key factors associated with adherence to physical exercise in patients with chronic diseases and older adults: an umbrella review","volume":"18","author":"Collado-Mateo","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026102211174666300_ref41","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1186\/s12872-020-01647-2","article-title":"The effect of problem-based learning after coronary heart disease\u2014a randomised study in primary health care (COR-PRIM)","volume":"20","author":"Kohler","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"2026102211174666300_ref42","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1136\/heartjnl-2016-310750","article-title":"Heart and mind: behavioural cardiology demystified for the clinician","volume":"105","author":"Astin","year":"2019","journal-title":"Heart"},{"key":"2026102211174666300_ref43","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1177\/2047487319846715","article-title":"Risk prediction tools in cardiovascular disease prevention: a report from the ESC prevention of CVD programme led by the European Association of Preventive Cardiology (EAPC) in collaboration with the acute cardiovascular care association (ACCA) and the Association of Cardiovascular Nursing and Allied Professions (ACNAP)","volume":"26","author":"Rossello","year":"2019","journal-title":"Eur J Prev Cardiol"},{"key":"2026102211174666300_ref44","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.mayocp.2014.04.033","article-title":"The prognostic importance of weight loss in coronary artery disease: a systematic review and meta-analysis","volume":"89","author":"Pack","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2026102211174666300_ref45","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"2026102211174666300_ref46","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref47","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.4065\/80.9.1157","article-title":"Safety and efficacy of bariatric surgery in patients with coronary artery disease","volume":"80","author":"Lopez-Jimenez","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"2026102211174666300_ref48","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"ESC scientific document group. 2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"2026102211174666300_ref49","doi-asserted-by":"publisher","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"2026102211174666300_ref50","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s40292-019-00336-2","article-title":"Treatment with free triple combination therapy of atorvastatin, perindopril, amlodipine in hypertensive patients: a real-world population study in Italy","volume":"26","author":"Perrone","year":"2019","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"2026102211174666300_ref51","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"CREDENCE trial investigators. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/dom.14226","article-title":"Sodium-glucose co-transporter-2 inhibitors with and without metformin: a meta-analysis of cardiovascular, kidney and mortality outcomes","volume":"23","author":"Neuen","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"2026102211174666300_ref53","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.mcna.2023.11.004","article-title":"Optimal medical therapy for chronic coronary disease in 2024: focus on antithrombotic therapy","volume":"108","author":"Patel","year":"2024","journal-title":"Med Clin North Am"},{"key":"2026102211174666300_ref54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15420\/ecr.2018.24.2","article-title":"Direct-acting anticoagulants in chronic coronary syndromes","volume":"15","author":"Sorbets","year":"2020","journal-title":"Eur Cardiol"},{"key":"2026102211174666300_ref55","doi-asserted-by":"publisher","first-page":"421","DOI":"10.2147\/VHRM.S338424","article-title":"Inclisiran: a new strategy for LDL-C lowering and prevention of atherosclerotic cardiovascular disease","volume":"19","author":"Albosta","year":"2023","journal-title":"Vasc Health Risk Manag"},{"key":"2026102211174666300_ref56","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1056\/NEJMoa1913805","article-title":"ORION-9 investigators. Inclisiran for the treatment of heterozygous familial hypercholesterolemia","volume":"382","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref57","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1056\/NEJMoa1912387","article-title":"ORION-10 and ORION-11 investigators. Two phase 3 trials of Inclisiran in patients with elevated LDL cholesterol","volume":"382","author":"Ray","year":"2020","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref58","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jacl.2022.12.001","article-title":"Efficacy and safety of pelacarsen in lowering Lp(a) in healthy Japanese subjects","volume":"17","author":"Karwatowska-Prokopczuk","year":"2023","journal-title":"J Clin Lipidol"},{"key":"2026102211174666300_ref59","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41569-021-00573-w","article-title":"A pathophysiological compass to personalize antianginal drug treatment","volume":"18","author":"Bertero","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"2026102211174666300_ref60","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1001\/archinte.1995.00430040023003","article-title":"The role of nitrates in coronary heart disease","volume":"155","author":"Abrams","year":"1995","journal-title":"Arch Intern Med"},{"key":"2026102211174666300_ref61","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026102211174666300_ref62","doi-asserted-by":"publisher","first-page":"e45487","DOI":"10.7759\/cureus.45487","article-title":"Role of glucagon-like Peptide-1 (GLP-1) receptor agonists in cardiovascular risk Management in Patients with type 2 diabetes mellitus: a systematic review","volume":"15","author":"Parab","year":"2023","journal-title":"Cureus"},{"key":"2026102211174666300_ref63","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"DAPA-HF trial committees and investigators. Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref64","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"EMPEROR-reduced trial investigators. Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref65","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"SUSTAIN-6 investigators. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref66","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"LEADER steering committee; LEADER trial investigators. Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref67","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.jacc.2021.06.037","article-title":"LoDoCo2 trial investigators. Colchicine in patients with chronic coronary disease in relation to prior acute coronary syndrome","volume":"78","author":"Opstal","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026102211174666300_ref68","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"LoDoCo2 trial investigators. Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref69","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1093\/eurheartj\/suab084","article-title":"Anti-inflammatory therapy in ischaemic heart disease: from canakinumab to colchicine","volume":"23","author":"Andreotti","year":"2021","journal-title":"Eur Heart J Suppl"},{"key":"2026102211174666300_ref70","doi-asserted-by":"publisher","first-page":"e138","DOI":"10.1093\/cvr\/cvab231","article-title":"From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?","volume":"117","author":"Ridker","year":"2021","journal-title":"Cardiovasc Res"},{"key":"2026102211174666300_ref71","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"CANTOS trial group. Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"2026102211174666300_ref72","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009217","article-title":"Estimated life expectancy without recurrent cardiovascular events in patients with vascular disease: the SMART-REACH model","volume":"7","author":"Kaasenbrood","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026102211174666300_ref73","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.jacc.2021.06.019","article-title":"Coronary computed tomographic angiography for complete assessment of coronary artery disease: JACC state-of-the-art review","volume":"78","author":"Serruys","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026102211174666300_ref74","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s11886-017-0935-x","article-title":"Stress echocardiography in stable coronary artery disease","volume":"19","author":"Gurunathan","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"2026102211174666300_ref75","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.hjc.2021.10.003","article-title":"Effects of different exercise programs on the cardiorespiratory reserve in HFpEF patients: a systematic review and meta-analysis","volume":"64","author":"Boulmpou","year":"2022","journal-title":"Hell J Cardiol"},{"key":"2026102211174666300_ref76","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/eurheartj\/ehac747","article-title":"Exercise-based cardiac rehabilitation for coronary heart disease: a meta-analysis","volume":"44","author":"Dibben","year":"2023","journal-title":"Eur Heart J"},{"key":"2026102211174666300_ref77","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12933-023-01875-8","article-title":"Intensified glycemic control by HbA1c for patients with coronary heart disease and type 2 diabetes: a review of findings and conclusions","volume":"22","author":"Chen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"2026102211174666300_ref78","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"ESC scientific document group. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"2026102211174666300_ref79","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3390\/medicina61020211","article-title":"Chronic heart failure and coronary artery disease: pharmacological treatment and cardiac rehabilitation","volume":"61","author":"Ciuca-Pan\u0103","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"2026102211174666300_ref80","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4103\/jmh.JMH_20_20","article-title":"Atypical manifestations of women presenting with myocardial infarction at tertiary health care Center: an analytical study","volume":"12","author":"Joseph","year":"2021","journal-title":"J Midlife Health"},{"key":"2026102211174666300_ref81","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1093\/ehjcvp\/pvad063","article-title":"External validity of the PRECISE-DAPT score in patients undergoing PCI: a systematic review and meta-analysis","volume":"9","author":"Munaf\u00f2","year":"2023","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"2026102211174666300_ref82","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"ESC scientific document group. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026102211174666300_ref83","doi-asserted-by":"publisher","first-page":"1823","DOI":"10.1016\/j.jacc.2019.08.1017","article-title":"Conference participants. Chronic kidney disease and coronary artery disease: JACC state-of-the-art review","volume":"74","author":"Sarnak","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2026102211174666300_ref84","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nrg.2016.160","article-title":"Genetics of coronary artery disease: discovery, biology and clinical translation","volume":"18","author":"Khera","year":"2017","journal-title":"Nat Rev Genet"},{"key":"2026102211174666300_ref85","doi-asserted-by":"publisher","first-page":"e055170","DOI":"10.1136\/bmjopen-2021-055170","article-title":"Use of artificial intelligence to assess the risk of coronary artery disease without additional (non-invasive) testing: validation in a low-risk to intermediate-risk outpatient clinic cohort","volume":"12","author":"Eurlings","year":"2022","journal-title":"BMJ Open"},{"key":"2026102211174666300_ref86","doi-asserted-by":"publisher","first-page":"100591","DOI":"10.1016\/j.jacadv.2023.100591","article-title":"Digital health programs to reduce readmissions in coronary artery disease: a systematic review and meta-analysis","volume":"2","author":"Braver","year":"2023","journal-title":"JACC Adv"},{"key":"2026102211174666300_ref87","doi-asserted-by":"publisher","first-page":"e0300250","DOI":"10.1371\/journal.pone.0300250","article-title":"Therapeutic education of patients with coronary heart disease: impact of digital platform monitoring in preventing major cardiovascular events in Tunisia: study protocol","volume":"19","author":"Ghali","year":"2024","journal-title":"PLoS One"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/102\/1213\/1008\/67498719\/qgag022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/102\/1213\/1008\/67498719\/qgag022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:17:55Z","timestamp":1792682275000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/102\/1213\/1008\/8539621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,24]]},"references-count":87,"journal-issue":{"issue":"1213","published-online":{"date-parts":[[2026,3,24]]},"published-print":{"date-parts":[[2026,10,22]]}},"URL":"https:\/\/doi.org\/10.1093\/postmj\/qgag022","relation":{},"ISSN":["0032-5473","1469-0756"],"issn-type":[{"value":"0032-5473","type":"print"},{"value":"1469-0756","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,11]]},"published":{"date-parts":[[2026,3,24]]}}}